VX-222/TELAPREVIR IN COMBINATION WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS TREATED FOR 12 WEEKS: ZENITH STUDY, SVR12 INTERIM ANALYSIS

被引：0
|
作者：
Nelson, David R. [1 ]
Gane, Edward J. [2 ]
Jacobson, Ira M. [3 ]
Di Bisceglie, Adrian M. [4 ]
Alves, Katia [5 ]
Koziel, Margaret J. [5 ]
De Souza, Cynthia [5 ]
Kieffer, Tara L. [5 ]
George, Shelley [5 ]
Rosario, Maria [5 ]
Kauffman, Robert S. [5 ]
Sulkowski, Mark S. [6 ]
机构：
[1] Univ Florida, Coll Med, Gainesville, FL USA
[2] Auckland City Hosp, Auckland, New Zealand
[3] Weill Cornell Med Coll, New York, NY USA
[4] St Louis Univ, Sch Med, St Louis, MO USA
[5] Vertex Pharmacuet Inc, Cambridge, MA USA
[6] Johns Hopkins Univ, Baltimore, MD USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1435A / 1435A
页数：1
相关论文
共 50 条
  • [1] VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTS
    Di Bisceglie, A. M.
    Nelson, D. R.
    Gane, E.
    Alves, K.
    Koziel, M. J.
    De Souza, C.
    Kieffer, T. L.
    George, S.
    Kauffman, R. S.
    Jacobson, I. M.
    Sulkowski, M. S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S540 - S540
  • [2] HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS
    Nelson, D. R.
    Lawitz, E.
    Bain, V.
    Gitlin, N.
    Hawkins, T.
    Marotta, P.
    Workowski, K.
    Flamm, S.
    Pang, P. S.
    McHutchison, J. G.
    McNally, J.
    Urbanek, P.
    Yoshida, E. M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S6 - S7
  • [3] CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY
    Zhang, E. Z.
    Tigges, A.
    Jiang, M.
    Dorrian, J.
    Spanks, J.
    Ardzinski, A.
    Alves, K.
    De Souza, C.
    Bartels, D. J.
    Koziel, M. J.
    Di Bisceglie, A. M.
    Kieffer, T. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S468 - S469
  • [4] VX-222, Telaprevir and Ribavirin in Treatment-Naive Patients with Genotype 1 Chronic Hepatitis C: Results of the ZENITH Study Interferon-Free Regimen
    Jacobson, Ira M.
    Sulkowski, Mark S.
    Gane, Edward J.
    Koziel, Margaret J.
    De Souza, Cynthia
    Kieffer, Tara L.
    Penney, Marina S.
    Zhang, Eileen Z.
    George, Shelley
    Kauffman, Robert S.
    Nelson, David R.
    Di Bisceglie, Adrian M.
    HEPATOLOGY, 2012, 56 : 308A - 308A
  • [5] ALL IL28B GENOTYPES HAVE HIGH SVR RATES IN PATIENTS TREATED WITH VX-222 IN COMBINATION WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN IN THE ZENITH STUDY
    Penney, M. S.
    De Souza, C.
    Seepersaud, S.
    Alves, K.
    Koziel, M. J.
    Kauffman, R. S.
    Di Bisceglie, A. M.
    Botfield, M. C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S476 - S477
  • [6] SVR12 is higher than SVR24 in treatment-naive hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
    Thorlund, Kristian
    Druyts, Eric
    Mills, Edward J.
    CLINICAL EPIDEMIOLOGY, 2014, 6 : 49 - 58
  • [7] EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR
    Poordad, F.
    McHutchison, J. G.
    Shiffman, M. L.
    Berg, T.
    Muir, A. J.
    Manns, M. P.
    Di Bisceglie, A. M.
    Terrault, N.
    Picchio, G.
    Kwong, A.
    Bengtsson, L.
    George, S.
    Adda, N.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S121 - S122
  • [8] Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
    Kumada, Hiromitsu
    Toyota, Joji
    Okanoue, Takeshi
    Chayama, Kazuaki
    Tsubouchi, Hirohito
    Hayashi, Norio
    JOURNAL OF HEPATOLOGY, 2012, 56 (01) : 78 - 84
  • [9] Telaprevir in Combination with Peginterferon and Ribavirin in Genotype 1 HCV Treatment-Naive Patients: Final Results of Phase 3 ADVANCE Study
    Ferenci, Peter
    Jacobson, Ira M.
    Adda, Nathalie
    Bengtsson, Leif
    George, Shelley
    Kauffman, Robert
    Zeuzem, Stefan
    SWISS MEDICAL WEEKLY, 2011, 141 : 3S - 3S
  • [10] TELAPREVIR IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: FINAL RESULTS OF PHASE 3 ADVANCE STUDY
    Jacobson, Ira M.
    McHutchison, John G.
    Dusheiko, Geoffrey M.
    Di Bisceglie, Adrian M.
    Reddy, Rajender
    Bzowej, Natalie H.
    Marcellin, Patrick
    Muir, Andrew J.
    Bengtsson, Leif
    Dunne, Ann Marie
    Adda, Nathalie
    George, Shelley
    Kauffman, Robert S.
    Zeuzem, Stefan
    HEPATOLOGY, 2010, 52 (04) : 427A - 427A
12345